Savvy Updates 2/17/25: 1st Rapid-Acting Biosimilar Insulin Approved, UVa AI-Powered Insulin Delivery, Susvimo for Diabetic Macular Edema, Oral Insulin Prevention Trial, GLP-1 Agonists Adhesive Capsulitis D, Protein-Rich, Low-Carb Diet & RA, D & Gum Disease & Flossing, Bone-Derived Hormone DKD, Insulin Resistance Predict OA, aD & Antibiotic-Resistance to Staph, ScotteVest & LOTS of POCKETS
In this week’s issue of The Savvy Diabetic: 1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased Risk of Adhesive Capsulitis in Diabetes...
ACTION ALERT from Breakthrough T1D: Tell Congress to Protect CRITICAL T1D Research and Cures!
From Breakthrough T1D / JDRF: TAKE ACTION!!! Tell Congress to Protect Critical T1D Research and Cures! Tell Your Members of Congress what we told Secretary Kennedy: there can be no actions that will slow progress toward cures! This is an easy way to make your voice...
Savvy Updates 2/10/25: Warning about SmartPhone Alert Settings, rBio Addresses Insulin Shortages, GlucoTrack Trial Success, Yo-Yo Dieting & Kidney Damage, Insulin Pump BACKUP Plan, Beta Bionics iLet Upgrades, Fake Research Papers, GAD Antibodies & T1D, Pebble Watch is Back, DIY Insulearner App, 3-Second Slices of Joy
In this week’s issue of The Savvy Diabetic: Warning about SmartPhone Alert Settings rBio Addresses Insulin Shortages GlucoTrack Trial Success Yo-Yo Dieting & Kidney Damage Insulin Pump BACKUP Plan (video) Beta Bionics iLet Upgrades (video) Fake...
Savvy Updates, 2/3/25: Ozempic OK’ed for Kidney Health, PREPARENESS & Go Bags, Anti-Aging Drugs, Sparkling Water & Weight Loss
FDA clears use of Ozempic to protect kidney health by Kristin Jensen for BioPharmaDive.com, 29 January 2025. Novo Nordisk won an expanded approval for Ozempic, allowing the company to market its top-selling medicine to reduce the risk of kidney complications in adults...
More Diabetes Blogs